PortfoliosLab logo
CAH vs. BIIB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CAH and BIIB is 0.41, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.4

Performance

CAH vs. BIIB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cardinal Health, Inc. (CAH) and Biogen Inc. (BIIB). The values are adjusted to include any dividend payments, if applicable.

3,500.00%4,000.00%4,500.00%5,000.00%5,500.00%6,000.00%NovemberDecember2025FebruaryMarchApril
5,991.04%
3,702.88%
CAH
BIIB

Key characteristics

Sharpe Ratio

CAH:

1.62

BIIB:

-1.35

Sortino Ratio

CAH:

2.23

BIIB:

-1.99

Omega Ratio

CAH:

1.30

BIIB:

0.77

Calmar Ratio

CAH:

1.95

BIIB:

-0.51

Martin Ratio

CAH:

8.46

BIIB:

-1.35

Ulcer Index

CAH:

4.19%

BIIB:

28.51%

Daily Std Dev

CAH:

21.90%

BIIB:

28.11%

Max Drawdown

CAH:

-61.58%

BIIB:

-90.00%

Current Drawdown

CAH:

-0.80%

BIIB:

-75.03%

Fundamentals

Market Cap

CAH:

$33.23B

BIIB:

$17.40B

EPS

CAH:

$5.37

BIIB:

$11.17

PE Ratio

CAH:

25.62

BIIB:

10.64

PEG Ratio

CAH:

0.90

BIIB:

6.24

PS Ratio

CAH:

0.15

BIIB:

1.80

PB Ratio

CAH:

16.07

BIIB:

1.04

Total Revenue (TTM)

CAH:

$167.41B

BIIB:

$7.27B

Gross Profit (TTM)

CAH:

$5.65B

BIIB:

$5.93B

EBITDA (TTM)

CAH:

$1.89B

BIIB:

$1.61B

Returns By Period

In the year-to-date period, CAH achieves a 17.24% return, which is significantly higher than BIIB's -22.29% return. Over the past 10 years, CAH has outperformed BIIB with an annualized return of 7.55%, while BIIB has yielded a comparatively lower -11.09% annualized return.


CAH

YTD

17.24%

1M

1.04%

6M

25.04%

1Y

35.66%

5Y*

25.07%

10Y*

7.55%

BIIB

YTD

-22.29%

1M

-15.31%

6M

-34.59%

1Y

-43.11%

5Y*

-17.13%

10Y*

-11.09%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CAH vs. BIIB — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CAH
The Risk-Adjusted Performance Rank of CAH is 9191
Overall Rank
The Sharpe Ratio Rank of CAH is 9393
Sharpe Ratio Rank
The Sortino Ratio Rank of CAH is 8989
Sortino Ratio Rank
The Omega Ratio Rank of CAH is 8888
Omega Ratio Rank
The Calmar Ratio Rank of CAH is 9393
Calmar Ratio Rank
The Martin Ratio Rank of CAH is 9393
Martin Ratio Rank

BIIB
The Risk-Adjusted Performance Rank of BIIB is 88
Overall Rank
The Sharpe Ratio Rank of BIIB is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of BIIB is 33
Sortino Ratio Rank
The Omega Ratio Rank of BIIB is 55
Omega Ratio Rank
The Calmar Ratio Rank of BIIB is 2020
Calmar Ratio Rank
The Martin Ratio Rank of BIIB is 1414
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CAH vs. BIIB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Cardinal Health, Inc. (CAH) and Biogen Inc. (BIIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for CAH, currently valued at 1.62, compared to the broader market-2.00-1.000.001.002.003.00
CAH: 1.62
BIIB: -1.35
The chart of Sortino ratio for CAH, currently valued at 2.23, compared to the broader market-6.00-4.00-2.000.002.004.00
CAH: 2.23
BIIB: -1.99
The chart of Omega ratio for CAH, currently valued at 1.30, compared to the broader market0.501.001.502.00
CAH: 1.30
BIIB: 0.77
The chart of Calmar ratio for CAH, currently valued at 1.95, compared to the broader market0.001.002.003.004.005.00
CAH: 1.95
BIIB: -0.51
The chart of Martin ratio for CAH, currently valued at 8.46, compared to the broader market-5.000.005.0010.0015.0020.00
CAH: 8.46
BIIB: -1.35

The current CAH Sharpe Ratio is 1.62, which is higher than the BIIB Sharpe Ratio of -1.35. The chart below compares the historical Sharpe Ratios of CAH and BIIB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.00NovemberDecember2025FebruaryMarchApril
1.62
-1.35
CAH
BIIB

Dividends

CAH vs. BIIB - Dividend Comparison

CAH's dividend yield for the trailing twelve months is around 1.47%, while BIIB has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
CAH
Cardinal Health, Inc.
1.47%1.28%1.98%2.57%3.80%3.62%3.80%4.24%3.00%2.41%1.68%1.65%
BIIB
Biogen Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

CAH vs. BIIB - Drawdown Comparison

The maximum CAH drawdown since its inception was -61.58%, smaller than the maximum BIIB drawdown of -90.00%. Use the drawdown chart below to compare losses from any high point for CAH and BIIB. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-0.80%
-75.03%
CAH
BIIB

Volatility

CAH vs. BIIB - Volatility Comparison

The current volatility for Cardinal Health, Inc. (CAH) is 9.82%, while Biogen Inc. (BIIB) has a volatility of 13.54%. This indicates that CAH experiences smaller price fluctuations and is considered to be less risky than BIIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%NovemberDecember2025FebruaryMarchApril
9.82%
13.54%
CAH
BIIB

Financials

CAH vs. BIIB - Financials Comparison

This section allows you to compare key financial metrics between Cardinal Health, Inc. and Biogen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items